Tomorrow Investor

Gold Terra Adds 595,000 Inferred Ounces within 5.1 Million Tonnes grading 3.64 g/t Au on the Con Mine Zone 103N in an Updated 2026 Mineral Resource Estimate, Yellowknife, NWT

Gold Terra Resource Corp Increases Inferred Gold Reserves | Accesswire

VANCOUVER, BC / ACCESS Newswire / May 15, 2026 / Gold Terra Resource Corp. (TSXV:YGT)(Frankfurt:TX0)(OTCQB:YGTFF) (“Gold Terra” or the “Company”) is pleased to announce the results of an updated, independent, Mineral Resource Estimate (“the 2026 MRE”) prepared by SLR Consulting (Canada) Ltd (“SLR”) on the Yellorex (“YRX”), Zone 103N, and Crestaurum deposits, part of its Yellowknife Project (“YP”), located near Yellowknife, NWT. A Technical Report, prepared in accordance with NI 43 101 Standards of Disclosure for Mineral Projects, will be filed on SEDAR within 45 days of this notice.

This excerpt is quoted from the original release. Read the full announcement on Accesswire.

Brief Summary

Gold Terra Resource Corp. recently announced a significant addition to its gold resources in the Yellowknife Project. The updated Mineral Resource Estimate reveals:

  • 595,000 inferred ounces of gold added
  • Total resource of 5.1 million tonnes grading 3.64 g/t
  • Independent review by SLR Consulting
  • Technical Report to be filed within 45 days

These additions reiterate Gold Terra’s commitment to resource growth and its potential to enhance shareholder value. Why it matters: Investors should be aware of the implications of increasing gold reserves in a growing market.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by Accesswire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.